Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,131.20
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,282.84
(
-0.75%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 87084

Monday, 12/07/2009 11:34:08 PM

Monday, December 07, 2009 11:34:08 PM

Post# of 257253
Quiz answer: A few companies are developing carbohydrate-based drugs for cancer, evidently. Nice catch on Progen, which has three such programs according to the company’s website:

http://www.progen.com.au/pipeline/angiogenesis.aspx

I don’t count MRK/GlycoFi as a quiz answer because I haven’t heard anything about a carbohydrate-based cancer drug in MRK’s pipeline. It’s been 3.5 years since the GlycoFi acquisition (#msg-11018747), presumably enough time for such a drug candidate to have surfaced if there were one.

The company I had in mind when posing the quiz question is GlycoMimetics, which was in the news today:

http://finance.yahoo.com/news/GlycoMimetics-Announces-Two-bw-3826323246.html?x=0&.v=1

Regards, Dew


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now